Company: DERM
Filing Date: 2025-08-28
Form Type: 424B3
Source: 0001104659-25-084876
Chunk: 46

Company: Journey Medical Corp
Filing Date: 2025-08-28
Form: 424B3
Chunk 46
---
 liquidity of or the existence of trading markets for any of the securities.

<div align='center'>17</div>

In order to facilitate the offering of the securities,
certain persons participating in the offering may engage in transactions that stabilize, maintain or otherwise affect the price of the
securities. This may include over-allotments or short sales of the securities, which involve the sale by persons participating in the
offering of more securities than we sold to them. In these circumstances, these persons would cover such over-allotments or short positions
by making purchases in the open market or by exercising their over-allotment option. In addition, these persons may stabilize or maintain
the price of the securities by bidding for or purchasing the applicable security in the open market or by imposing penalty bids, whereby
selling concessions allowed to dealers participating in the offering may be reclaimed if the securities sold by them are repurchased in
connection with stabilization transactions. The effect of these transactions may be to stabilize or maintain the market price of the securities
at a level above that which might otherwise prevail in the open market. These transactions may be discontinued at any time.

In compliance with the guidelines of the Financial
Industry Regulatory Authority, Inc., or FINRA, the maximum consideration or discount to be received by any FINRA member or independent
broker dealer may not exceed 8% of the aggregate amount of the securities offered pursuant to this prospectus and any applicable prospectus
supplement.

The underwriters, dealers and agents may engage
in other transactions with us, or perform other services for us, in the ordinary course of their business.

<div align='center'>LEGAL MATTERS</div>

The validity of the securities and certain other
matters will be passed upon for us by McGuireWoods LLP, Charlotte, North Carolina. Additional legal matters may be passed upon for us
or any underwriters, dealers or agents, by counsel that we name in the applicable prospectus supplement.

<div align='center'>EXPERTS</div>

The consolidated financial statements of Journey
Medical Corporation as of December 31, 2021 and 2020 and for each of the years then ended have been incorporated by reference herein in
reliance upon the report of KPMG LLP, an independent registered public accounting firm, incorporated by reference herein, and upon the
authority of said firm as experts in accounting and auditing.

<div align='center'>WHERE YOU CAN FIND MORE INFORMATION</div>

We are a reporting company and file annual, quarterly